Diasino

With more than 10 years experiences and know how in the filed of IVD, today DiaSino's activity is not only to provide quality and cost effective products to clincal labs and hospitals but also offer smartphone based iPOCT devices and health management solutions to personals. DiaSino Laboratories, Inc. was founded in New York, USA, as our Research C... enter, specializing in design and R&D of iPOCT. Launched in 2014, the Thyroid ELISA unveiled DiaSino's activity in IVD. From there, DiaSino had developed a wide range of ELISA assays including fertility, tumor markers, anemia, infectious disease, autoimmune, bone metalbolism and etc. DiaSino's ELISA kits are produced at its OEM factory in eastern part of Zhengzhou, China. In 2017, DiaCard Vaginitis Multitest unveiled DiaSino's cutting-edge measurement and data transfer technology on iPOCT project. Today 9 patents related to this project has already been filed at the State Intellectual Property Office of The P.R.C (SIPO). Meanwhile, the applications of the intellectual property in some countries outside China are also moving ahead. In earlier 2018, DiaSino invested in a clinical chemistry manufacturer, and after that more than 60 clinical chemistry reagents were added on DiaSino's products portfolio. This company has been running for 7 years and the technical team had nearly 20 years experiences and know how in this field. The purpose of starting on this line is to meet our customers' needs that who wants the customized and bulk sized reagents with high level quality and transfer prices. The products are produced at the factory in western part of Zhengzhou, China. Today, DiaSino's products have been sold in more than 50 countries around the world and it continues to provide quality products and excellent services to customers. DiaSino's mission is as the diagnostic exlorer to bring quality to clinical labs and to bring clinical labs home. Key contacts in DiaSinoRead More